Date Name Title Filing Type Shares Traded Price Total Held
Dec 14, 2010
SVP Clinical Development
SVP Clinical Development Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 28,736 -- 28,736
Feb 13, 2012
SVP Research and Development S
SVP Research and Development S Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 28,869 $113.35 88,745
Dec 16, 2015
SVP Finance & CFO
SVP Finance & CFO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 28,900 -- 28,900
Dec 16, 2015
SVP General Counsel and Secret
SVP General Counsel and Secret Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 28,900 -- 28,900
May 02, 2012
SVP Finance and Admin CFO Trea
SVP Finance and Admin CFO Trea Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 29,000 $21.92 120,681
May 02, 2012
SVP Finance and Admin CFO Trea
SVP Finance and Admin CFO Trea Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 29,000 -- --
Feb 22, 2023
Director
Director Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 29,005 $750.16 337,578
May 06, 2013
SVP & General Mgr Industrial O
SVP & General Mgr Industrial O Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 29,048 $16.80 39,784
May 06, 2013
SVP & General Mgr Industrial O
SVP & General Mgr Industrial O Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 29,048 -- 52,500
Dec 17, 2008
SVP & GM, Ind Ops & Prod Supp
SVP & GM, Ind Ops & Prod Supp Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 29,048 -- 29,048

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.